Literature DB >> 15186401

Activation of human dendritic cells by the PorA protein of Neisseria meningitidis.

Tamara Al-Bader1, Keith A Jolley, Holly E Humphries, Judith Holloway, John E Heckels, Amanda E Semper, Peter S Friedmann, Myron Christodoulides.   

Abstract

The major porin proteins present in the outer membrane of Neisseria meningitidis, the causative agent of life-threatening meningitis and septicaemia, are believed to have potent immunostimulatory effects. In this study, the interactions between human monocyte-derived dendritic cells (mo-DC) and the PorA porin were investigated, in order to reveal the role of this protein in promoting innate and adaptive immune responses. Recombinant (r)PorA induced mo-DC maturation, as reflected by reduced receptor-mediated endocytosis, increased production of the chemokines IL-8, RANTES, MIP-1 alpha and MIP-1 beta and augmented expression of the surface markers CD40, CD54, CD80, CD86 and major histocompatibility complex class II molecules. However, rPorA induced either low level or no significant secretion of pro-inflammatory cytokines from mo-DC. The protein potently augmented the capacity of mo-DC to activate both allogeneic CD4(+) memory T-cells and CD4(+)RA(+) naïve T-cells. In addition, rPorA appeared to inhibit the production of IL-12p70 that follows from the interaction between CD40 on the mo-DC and CD40-ligand on T-cells, thereby directing T-cell differentiation towards a Th2 type response. These data demonstrate that PorA is involved in DC activation and in influencing the nature of the T-helper immune response, which are important properties for generating antibody responses required for protective immunity against meningococci and for determining the immuno-adjuvant effects of this protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15186401     DOI: 10.1111/j.1462-5822.2004.00392.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  7 in total

Review 1.  The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease.

Authors:  Hendrik Schultz; Jerrold P Weiss
Journal:  Clin Chim Acta       Date:  2007-07-13       Impact factor: 3.786

2.  Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein activates dendritic cells and induces a Th1 polarization.

Authors:  Jun Sik Lee; Sung Jae Shin; Michael T Collins; In Duk Jung; Young-Il Jeong; Chang-Min Lee; Yong Kyoo Shin; Daejin Kim; Yeong-Min Park
Journal:  Infect Immun       Date:  2009-04-27       Impact factor: 3.441

3.  Anti-tumor activity of Acinetobacter baumannii outer membrane protein A on dendritic cell-based immunotherapy against murine melanoma.

Authors:  Jun Sik Lee; Jung Wook Kim; Chul Hee Choi; Won Kee Lee; Hae Young Chung; Je Chul Lee
Journal:  J Microbiol       Date:  2008-06-11       Impact factor: 3.422

4.  Disease-associated Neisseria meningitidis isolates inhibit wound repair in respiratory epithelial cells in a type IV pilus-independent manner.

Authors:  Xiaoyun Ren; Joanna K MacKichan
Journal:  Infect Immun       Date:  2014-09-15       Impact factor: 3.441

5.  The biology of Neisseria adhesins.

Authors:  Miao-Chiu Hung; Myron Christodoulides
Journal:  Biology (Basel)       Date:  2013-07-29

6.  Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice.

Authors:  Ojas H Mehta; Gunnstein Norheim; J Claire Hoe; Christine S Rollier; Jerry C Nagaputra; Katherine Makepeace; Muhammad Saleem; Hannah Chan; David J P Ferguson; Claire Jones; Manish Sadarangani; Derek W Hood; Ian Feavers; Jeremy P Derrick; Andrew J Pollard; E Richard Moxon
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

Review 7.  The Host-Pathogen Interactions and Epicellular Lifestyle of Neisseria meningitidis.

Authors:  August Mikucki; Nicolie R McCluskey; Charlene M Kahler
Journal:  Front Cell Infect Microbiol       Date:  2022-04-22       Impact factor: 6.073

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.